Axio Capital executed a management buyout of Laboratoire Benewmedical, positioning the company for significant growth in the regenerative surgery market.
Target Company Overview
Laboratoire Benewmedical is a distributor of innovative medical devices that offer significant medical-economic value. Initially established as a pure trading company, the organization has transitioned towards becoming a manufacturer, adopting an audacious and forward-thinking position in innovative surgical technologies, particularly in the field of regenerative surgery.
The company sources and negotiates distribution agreements, thus ensuring the market introduction of products for which it holds distribution mandates, as well as their quality and safety. Laboratoire Benewmedical offers approximately 800 references across three product divisions: regenerative surgery, general surgery, and outpatient services.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in France
The medical device industry in France is a vital sector characterized by rapid innovation and an increasing emphasis on higher quality healthcare solutions. France remains one of the
Similar Deals
Dentressangle → Naturacare et Dietopack
2023
ARCHIMED → FIM Medical
2023
Axio Capital → Benewmedical
2023
Turenne Santé → VLAD
2023
Axio Capital
invested in
Laboratoire Benewmedical
in 2023
in a Management Buyout / Buy-In (MBO) deal